Non-invasive method to detect the changes of glucose concentration in whole blood using photometric technique

A non-invasive method is developed to monitor rapid changes in blood glucose levels in diabetic patients. The system depends on an optical cell built with a LED that emits light of wavelength 535nm, which is a peak absorbance of hemoglobin. As the glucose concentration in blood decreases, its osmolarity also decreases and the Red Blood Cells (RBCs) swell and decrease the path length absorption coefficient. Decreasing absorption coefficient increases the transmission of light through the whole blood. The system was tested with a constructed optical cell that held whole blood in a capillary tube. As expected the light transmitted to the photodiode increases with decreasing glucose concentration. The average response time of the system was between 30-40 seconds.

[1]  M. Friebel,et al.  Influence of osmolarity on the optical properties of human erythrocytes. , 2010, Journal of biomedical optics.

[2]  J. Jansen,et al.  Influence of inflammatory cells and serum on the performance of implantable glucose sensors. , 2001, Journal of biomedical materials research.

[3]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[4]  D. Coustan,et al.  Gestational diabetes mellitus. , 2013, Clinical chemistry.

[5]  Martina Meinke,et al.  Determination of optical properties of human blood in the spectral range 250 to 1100 nm using Monte Carlo simulations with hematocrit-dependent effective scattering phase functions. , 2006, Journal of biomedical optics.

[6]  L Heinemann,et al.  Noninvasive glucose measurement by monitoring of scattering coefficient during oral glucose tolerance tests. Non-Invasive Task Force. , 2000, Diabetes technology & therapeutics.

[7]  T. B. Blank,et al.  Noninvasive prediction of glucose by near-infrared diffuse reflectance spectroscopy. , 1999, Clinical chemistry.

[8]  M. Maizels,et al.  EFFECTS OF STORAGE ON HUMAN ERYTHROCYTES , 1940 .

[9]  D. Williamson,et al.  Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence , 2010, Population health metrics.

[10]  Carlos Eduardo Ferrante do Amaral,et al.  Current development in non-invasive glucose monitoring. , 2008, Medical engineering & physics.

[11]  M. Craggs,et al.  Interface pressure and cutaneous hemoglobin and oxygenation changes under ischial tuberosities during sacral nerve root stimulation in spinal cord injury. , 2006, Journal of rehabilitation research and development.

[12]  R. Waynant,et al.  Light promotes regeneration and functional recovery and alters the immune response after spinal cord injury , 2005, Lasers in surgery and medicine.

[13]  D. Klonoff.  Continuous glucose monitoring: roadmap for 21st century diabetes therapy. , 2005, Diabetes care.

[14]  H. Wulf,et al.  Influence of Epidermal Thickness, Pigmentation and Redness on Skin Autofluorescence¶ , 2003 .

[15]  Fotios Papadimitrakopoulos,et al.  A Review of the Biocompatibility of Implantable Devices: Current Challenges to Overcome Foreign Body Response , 2008, Journal of diabetes science and technology.

[16]  W M Reichert,et al.  Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. , 1998, Journal of biomedical materials research.

[17]  H. Wulf,et al.  Influence of Epidermal Thickness, Pigmentation and Redness on Skin Autofluorescence ¶ , 2003, Photochemistry and photobiology.

[18]  O. Khalil,et al.  Non-invasive glucose measurement technologies: an update from 1999 to the dawn of the new millennium. , 2004, Diabetes technology & therapeutics.

[19]  L. Heinemann,et al.  Non-invasive continuous glucose monitoring in Type I diabetic patients with optical glucose sensors , 1998, Diabetologia.

[20]  M. Redondo,et al.  Genetics of type 1A diabetes. , 2001, Recent progress in hormone research.

[21]  G. Voskerician,et al.  Electrochemical characterization and in vivo biocompatibility of a thick-film printed sensor for continuous in vivo monitoring , 2005, IEEE Sensors Journal.

[22]  A. Maran,et al.  Non-invasive glucose monitoring: assessment of technologies and devices according to quantitative criteria. , 2007, Diabetes research and clinical practice.

[23]  L. Heinemann,et al.  Sensors for glucose monitoring: technical and clinical aspects , 2001, Diabetes/metabolism research and reviews.

[24]  M. Shults,et al.  Evaluation of a Subcutaneous Glucose Sensor out to 3 Months in a Dog Model , 1994, Diabetes Care.

[25]  Heidi E Koschwanez,et al.  In vitro, in vivo and post explantation testing of glucose-detecting biosensors: current methods and recommendations. , 2007, Biomaterials.

[26]  A H Clemens,et al.  The development of Biostator, a Glucose Controlled Insulin Infusion System (GCIIS). , 1977, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[27]  J. Mastrototaro,et al.  The MiniMed Continuous Glucose Monitoring System (CGMS). , 1999, Journal of pediatric endocrinology & metabolism : JPEM.

[28]  Jody T. Bruulsema,et al.  Correlation between blood glucose concentration in diabetics and noninvasively measured tissue optical scattering coefficient. , 1997, Optics letters.

[29]  F. Chee,et al.  Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time , 2003, IEEE Transactions on Information Technology in Biomedicine.

[30]  U Fischer,et al.  Subcutaneous glucose monitoring by means of electrochemical sensors: fiction or reality? , 1992, Journal of biomedical engineering.